Join the watch

Allergan Plc

$173
AGN - NYSE
Dividend yield
-
Payout ratio
-
P/E (12m)
-
EPS
-
Allergan Plc description

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States.

The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

Company profile
Market cap
Mega (56.92B)
Company CEO
Brenton L. Saunders
AGN dividends payouts